| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 07/14/2011 | US20110171299 Doxycycline metal complex in a solid dosage form |
| 07/14/2011 | US20110171287 Use of Oligonucleotides with Modified Bases as Antiviral Agents |
| 07/14/2011 | US20110171285 Design of Fibrinogen and Fibrinogen Derived Products with Reduced Bacterial Binding by Using Modified Sequences of Fibrinogen Chains |
| 07/14/2011 | US20110171283 Composition containing at least one nutrivite, at least one disinfecting or decontaminating, and/or at least one protease-inhibiting active compound and/or active compound complex |
| 07/14/2011 | US20110171272 Urological medical devices for release of prostatically beneficial therapeutic agents |
| 07/14/2011 | US20110171263 Compositions and methods of use of orf-1358 from beta-hemolytic streptococcal strains |
| 07/14/2011 | US20110171261 Immunogenic composition |
| 07/14/2011 | US20110171260 Influenza dna vaccination and methods of use thereof |
| 07/14/2011 | US20110171259 Novel Compositions and Adjuvants |
| 07/14/2011 | US20110171258 Polyvalent, primary hiv-1 glycoprotein dna vaccines and vaccination methods |
| 07/14/2011 | US20110171257 Herpes simplex virus amplicon vectors derived from primary isolates |
| 07/14/2011 | US20110171255 Expression vector encoding alphavirus replicase and the use thereof as immunological adjuvant |
| 07/14/2011 | US20110171253 Novel astrovirus |
| 07/14/2011 | US20110171252 Streptococcus suis vaccines and diagnostic tests |
| 07/14/2011 | US20110171250 Synthetic Gene Construct Coding for an HIV1 GAG and Use Thereof for Obtaining Anti-HIV-1 Vaccines |
| 07/14/2011 | US20110171249 Chimeric chikungunya virus and uses thereof |
| 07/14/2011 | US20110171248 Synthetic virus-like particles conjugated to human papillomavirus capsid peptides for use as vaccines |
| 07/14/2011 | US20110171244 Recombinant protein carrying human papillomavirus epitopes inserted in an adenylate cyclase protein or fragment thereof therapeutic uses thereof |
| 07/14/2011 | US20110171242 Ligand for herpes simplex virus entry mediator and methods of use |
| 07/14/2011 | US20110171237 Phep, an amino acid permease of staphylococcus aureus |
| 07/14/2011 | US20110171236 Anthrax and small pox replikins and methods of use |
| 07/14/2011 | US20110171234 Vaccine |
| 07/14/2011 | US20110171233 Antibodies Against Human Cytomegalovirus (HCMV) |
| 07/14/2011 | US20110171231 ANTI-PlGF ANTIBODIES AND METHODS USING SAME |
| 07/14/2011 | US20110171224 PsrP IS A PROTECTIVE ANTIGEN AGAINST PNEUMOCOCCAL INFECTION |
| 07/14/2011 | US20110171223 Anti-peptide antibodies that cross react with protective antigen of bacillus anthracis and uses thereof |
| 07/14/2011 | US20110171218 Compositions and methods for increasing serum half-life |
| 07/14/2011 | US20110171210 Humanized monoclonal antibodies and methods of use |
| 07/14/2011 | US20110171195 Methods and compositions for treating urinary tract infections using agents that mimic or elevate cyclic amp |
| 07/14/2011 | US20110171189 Compositions and methods comprising serratia peptidase for inhibition and treatment of biofilms related to certain conditions |
| 07/14/2011 | US20110171177 Compositions and Methods for Inhibiting Entry of a Hepatic Virus |
| 07/14/2011 | US20110171175 Inhibitors of serine proteases |
| 07/14/2011 | US20110171174 Synergistic Combinations of a Macrocyclic Inhibitor of HCV and a Nucleoside |
| 07/14/2011 | US20110171172 Compounds for inhibiting ksp kinesin activity |
| 07/14/2011 | US20110171162 Polymer conjugates of thymosin alpha 1 peptides |
| 07/14/2011 | US20110171161 Polymer conjugates of protegrin peptides |
| 07/14/2011 | US20110171143 Method of maintaining oral health in animals |
| 07/14/2011 | US20110171125 ANTI-FcRH5 ANTIBODIES AND IMMUNOCONJUGATES AND METHODS OF USE |
| 07/14/2011 | CA2786306A1 Methods and compositions for providing protective immunity in the elderly |
| 07/14/2011 | CA2785612A1 Ev576 for use in the treatment of viral infections of the respiratory tract |
| 07/14/2011 | CA2785226A1 Photo-inactivated viruses and systems and methods of using the same |
| 07/14/2011 | CA2784973A1 New synergistic compositions for the treatment of topical viral infections |
| 07/13/2011 | EP2343320A1 GITR binding molecules and uses therefor |
| 07/13/2011 | EP2343308A2 Novel immunogenic compositions for the prevention and treatment of meningococcal disease |
| 07/13/2011 | EP2343304A1 Biocidal boronophthalide compounds |
| 07/13/2011 | EP2343293A1 Novel piperidin-4-yl-thiazole-carboxamide analogues as inhibitors of t-cell proliferation and uses thereof |
| 07/13/2011 | EP2343289A1 Amorphous (R)-2-[[[3-methyl-4-(2,2,2-trifluoroethoxy)-2-pyridinyl]methyl]sulfinyl]-1H-benzimidazole as anti-ulcer agent |
| 07/13/2011 | EP2343285A2 Peptoid compounds |
| 07/13/2011 | EP2343088A1 Antimycotic and prebiotic pharmaceutical composition and a method for treating candidal vaginitis |
| 07/13/2011 | EP2343081A1 Interferon analogs |
| 07/13/2011 | EP2343072A1 Remedy |
| 07/13/2011 | EP2343069A1 Heterocyclic aspartyl protease inhibitors |
| 07/13/2011 | EP2343066A1 Therapeutic agent for hepatitis c |
| 07/13/2011 | EP2343065A1 The pharmaceutical composition containing ferulic acid and matrine compounds, the preparation and the use thereof |
| 07/13/2011 | EP2343038A1 Dermatological compositions comprising a combination of peroxidized lipids and zinc for use amongst others in the treatment of herpes |
| 07/13/2011 | EP2342335A1 Novel gene cluster |
| 07/13/2011 | EP2342226A2 Human anti-pd-1, pd-l1, and pd-l2 antibodies and uses therefor |
| 07/13/2011 | EP2342205A1 Substituted tricyclic acid derivatives as s1p1 receptor agonists useful in the treatment of autoimmune and inflammatory disorders |
| 07/13/2011 | EP2341939A2 Dendritic cell modulatory molecule |
| 07/13/2011 | EP2341930A1 Outer membrane vesicle prime - protein boost vaccine |
| 07/13/2011 | EP2341929A1 Compositions and methods related to bacterial eap, emp, and/or adsa proteins |
| 07/13/2011 | EP2341928A1 Mycobacterium tuberculosis vaccine |
| 07/13/2011 | EP2341907A1 Synergistic combinations of a macrocyclic inhibitor of hcv and a nucleoside |
| 07/13/2011 | EP2098598B1 Screening method for prophylactic and/or therapeutic agent for disease accompanied by hepatitis c |
| 07/13/2011 | EP1828247B1 Binding molecules capable of neutralizing west nile virus and uses thereof |
| 07/13/2011 | EP1778702B1 Antiviral compounds |
| 07/13/2011 | EP1765398B1 Human antibodies interacting with hiv gp41 |
| 07/13/2011 | EP1755576B1 Antimicrobial compositions and methods for their use |
| 07/13/2011 | EP1562913B1 Substituted quinazolines as antiviral agents, especially against cytomegaloviruses |
| 07/13/2011 | EP1509489B1 Amines that inhibit a mammalian anandamide transporter, and methods of use thereof |
| 07/13/2011 | EP1465990B1 Truncated lysostaphin molecule with enhanced staphylolytic activity |
| 07/13/2011 | EP1463502B1 Broadspectrum heterocyclic substituted phenyl containing sulfonamide hiv protease inhibitors |
| 07/13/2011 | EP1178825B1 Adjuvant combination formulations |
| 07/13/2011 | EP0979080B1 A method of modulating an immune response in an infected mammal by transmucosal administration of modulating agent |
| 07/13/2011 | CN1957938B Effervescence tablet of Glucurolactone, and preparation method |
| 07/13/2011 | CN1903846B Ornidazole derivative used for therapy, its preparation method and use |
| 07/13/2011 | CN1883599B Chinese medicinal composition for treating women's episioitis or colpitis and method for preparing same |
| 07/13/2011 | CN1353609B Amide substituted imidazoquinolines |
| 07/13/2011 | CN102124028A Monoclonal antibodies having homosubtype cross -neutralization properties against influenza a viruses subtype h1 |
| 07/13/2011 | CN102124012A Macrocyclic indole derivatives useful as hepatitis C virus inhibitors |
| 07/13/2011 | CN102124011A Inhibitors of human immunodeficiency virus replication |
| 07/13/2011 | CN102123736A Antimycotic and prebiotic pharmaceutical composition and a method for treating candidal vaginitis |
| 07/13/2011 | CN102123724A Compositions and methods for treating influenza |
| 07/13/2011 | CN102123719A Plant extract and its therapeutic use |
| 07/13/2011 | CN102123716A Compositions and methods for treating viral infections |
| 07/13/2011 | CN102123706A Use of paf receptor for treating infections caused by flaviviridae |
| 07/13/2011 | CN102120988A Recombinant porcine circovirus type 2 strain expressing V5 epitope tag and application thereof |
| 07/13/2011 | CN102120987A Construction of four different sub-genotypes of porcine circovirus type 2 molecular cloning strains and application thereof |
| 07/13/2011 | CN102120760A Antibacterial peptide derived from phage and application thereof |
| 07/13/2011 | CN102120759A Polypeptide as well as derivatives and application thereof |
| 07/13/2011 | CN102120751A Nucleoside compound with anti-cancer and anti-virus activities, and preparation method and application thereof |
| 07/13/2011 | CN102120747A Water-soluble photostable silver (I) complex and preparation method and application thereof |
| 07/13/2011 | CN102120045A Probiotics-containing female hygienic product as well as preparation method and application thereof |
| 07/13/2011 | CN102120030A Medicament of ilaprazole chemical structure and application thereof |
| 07/13/2011 | CN102120028A Method for extracting lipopolysaccharides from avian pasteurella multocida and preparing lipopolysaccharide vaccine |
| 07/13/2011 | CN102120008A Traditional Chinese medicine for treating icteric hepatitis |
| 07/13/2011 | CN102120000A Composition of effective parts of traditional Chinese medicine preparation for resisting Coxsackie virus B and preparation method thereof |
| 07/13/2011 | CN102119978A Composition for relieving exterior syndrome and clearing away heat and toxic materials, and preparation method and detection method thereof |
| 07/13/2011 | CN102119966A Preparation method of Chinese medicinal preparation for treating hepatitis disease by microwave-assisted extraction |
| 07/13/2011 | CN102119956A Application of lignum dalbergiae odoriferae oil in preparing medicament for resisting human pathogenic bacteria and lignum dalbergiae odoriferae perfume |